# Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis

> **NCT00583895** · PHASE2 · TERMINATED · sponsor: **Valletta Health B.V.** · enrollment: 25 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** 10% ImCOOH cream
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00583895
- **Lead sponsor:** Valletta Health B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 25 (ESTIMATED)
- **Why stopped:** Recruitment problems; insufficient number of new recruits
- **Last updated:** 2010-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00583895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00583895, "Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00583895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*